Atlas Trials

Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide

Clinical trial NCT00125606 · TERMINATED

Trial details

NCT number
NCT00125606
Sponsor
University Hospital Muenster
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2004-10-01
Primary completion
2011-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.